The 14-membered cycloisodityrosine is the core structure of RA-series antitumor bicyclic peptides obtained from Rubia plants (Rubiaceae). In this study, an efficient method for the synthesis of cycloisodityrosines from commercially available L-tyrosine derivatives was developed. Using synthetic cycloisodityrosines and cycloisodityrosines with modified structures, several RA-VII analogues were designed and synthesized to explore structure-activity relationships of the cycloisodityrosine moiety of the RA-series peptides, and newly isolated natural peptides were synthesized to establish their structures.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397687 | PMC |
| http://dx.doi.org/10.1007/s11418-021-01542-w | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Caryophyllene Oxide, a Bicyclic Terpenoid Isolated from with Antitumor Activity: In Vivo, In Vitro, and In Silico Studies.
Int J Mol Sci
December 2024
Unidad de Investigación Médica en Farmacología, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City CP 06720, Mexico.
The Annona genus contains some species used in Mexican traditional medicine for the treatment cancer, including . The present study aimed to investigate the anticancer activity of caryophyllene oxide (CO) isolated from using in vivo, in vitro, and in silico approaches. The identification of CO was performed using gas chromatography-mass spectroscopy and NMR methods.
View Article and Find Full Text PDFSynthesis of Antitumor Bicyclic Hexapeptide RA-VII Analogues Possessing an Aromatic Amino Acid at Residue 2.
J Org Chem
November 2024
School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.
RA-III acetate was treated with Lawesson's reagent to afford [Tyr-3-Ψ(CS-NH)-Ala-4]RA-III acetate. Treatment of this product with Hg(OAc)/LiCO and then methanol gave an oxazole intermediate. Acid-catalyzed arylation of the methylene carbon atom on the oxazole ring and subsequent partial hydrolysis of the oxazole ring in the resultant compounds afforded RA-VII analogues having an aromatic amino acid at residue 2.
View Article and Find Full Text PDFMaydisens, Sesterterpenoids with Anti-MDR Activity from .
J Nat Prod
October 2024
Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, People's Republic of China.
Fourteen previously undescribed sesterterpenoids (-) were isolated from . Their structures with absolute configurations were elucidated by NMR, HRESIMS, DP4+ calculations, ECD calculations, single-crystal X-ray diffraction analyses, and the modified Mosher's method. Compounds - possess an uncommon 5/11 bicyclic ring system identified from for the first time.
View Article and Find Full Text PDFCan Alpha-Pinene Prevent Methotrexate-Induced Cardiac and Hepatic Damage?
Physiol Res
August 2024
Ordu University, Medical Faculty, Physiology Department, Ordu, Turkiye.
Article Synopsis
- Scientists studied how a substance called alpha-pinene (AP) could help protect the heart and liver from damage caused by a medicine called methotrexate (MTX).
- They tested this by using rats and found that MTX caused a lot of harm to the heart and liver, but when the rats got AP before the MTX, the damage was much less.
- This suggests that alpha-pinene might be a helpful way to protect the heart and liver during cancer treatments that use methotrexate.
Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide.
Theranostics
September 2024
Department of Nuclear Medicine, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106 Freiburg, Germany.
Erythropoietin-producing hepatocellular receptor A2 (EphA2), is a receptor tyrosine kinase involved in cell-cell interactions. It is known to be overexpressed in various tumors and is associated with poor prognosis. EphA2 has been proposed as a target for theranostic applications.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!